van Waarde A - Search Results

1

Molecular imaging: what can be used today.

Jager PL, de Korte MA, Lub-de Hooge MN, van Waarde A, Koopmans KP, Perik PJ, de Vries EG. Jager PL, et al. Among authors: van waarde a. Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S27-32. doi: 10.1102/1470-7330.2005.0023. Cancer Imaging. 2005. PMID: 16361133 Free PMC article. Review.

2

In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET.

Willemsen AT, van Waarde A, Paans AM, Pruim J, Luurtsema G, Go KG, Vaalburg W. Willemsen AT, et al. Among authors: van waarde a. J Nucl Med. 1995 Mar;36(3):411-9. J Nucl Med. 1995. PMID: 7884503 Free article.

3

Imaging beta-adrenoceptors in the human brain with (S)-1'-[18F]fluorocarazolol.

van Waarde A, Visser TJ, Elsinga PH, de Jong B, van der Mark TW, Kraan J, Ensing K, Pruim J, Willemsen AT, Brodde OE, Visser GM, Paans AM, Vaalburg W. van Waarde A, et al. Among authors: van der mark tw. J Nucl Med. 1997 Jun;38(6):934-9. J Nucl Med. 1997. PMID: 9189145 Free article.

4

On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain.

Passchier J, van Waarde A, Vaalburg W, Willemsen AT. Passchier J, et al. Among authors: van waarde a. J Nucl Med. 2001 Jul;42(7):1025-31. J Nucl Med. 2001. PMID: 11438622 Free article.

5

Positron emission tomography: the conceptual idea using a multidisciplinary approach.

Paans AM, van Waarde A, Elsinga PH, Willemsen AT, Vaalburg W. Paans AM, et al. Among authors: van waarde a. Methods. 2002 Jul;27(3):195-207. doi: 10.1016/s1046-2023(02)00075-0. Methods. 2002. PMID: 12183107 Review.

6

Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003.

Cobben DC, Elsinga PH, van Waarde A, Jager PL. Cobben DC, et al. Among authors: van waarde a. Cancer Res. 2003 Dec 1;63(23):8558-9; author reply 8560. Cancer Res. 2003. PMID: 14679027 No abstract available.

7

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, Jager PL, Hoekstra HJ, Elsinga PH. van Waarde A, et al. J Nucl Med. 2004 Apr;45(4):695-700. J Nucl Med. 2004. PMID: 15073267 Free article.

8

Receptor imaging in the thorax with PET.

Elsinga PH, van Waarde A, Vaalburg W. Elsinga PH, et al. Among authors: van waarde a. Eur J Pharmacol. 2004 Sep 19;499(1-2):1-13. doi: 10.1016/j.ejphar.2004.06.057. Eur J Pharmacol. 2004. PMID: 15363946 Review.

9

Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study.

van Waarde A, Buursma AR, Hospers GA, Kawamura K, Kobayashi T, Ishii K, Oda K, Ishiwata K, Vaalburg W, Elsinga PH. van Waarde A, et al. J Nucl Med. 2004 Nov;45(11):1939-45. J Nucl Med. 2004. PMID: 15534066 Free article.

10

Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.

de Vries EF, Kortekaas R, van Waarde A, Dijkstra D, Elsinga PH, Vaalburg W. de Vries EF, et al. Among authors: van waarde a. J Nucl Med. 2005 Aug;46(8):1384-92. J Nucl Med. 2005. PMID: 16085598 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters